Portfolio of Synthetic Biology Stocks
Here is a table of 4 synthetic biology stocks.
| 4 Synthetic Biology Stocks | ||
|---|---|---|
Stock Returns & Price Chart | Symbol | Recent Prices & |
| Amyris | AMRS | |
| Codexis | CDXS | |
| Gevo | GEVO | |
| ZIOPHARM Oncology | ZIOP | |
| Price data from Quandl as of most recent close. | ||
| 4 Synthetic Biology Stocks | ||
|---|---|---|
Stock Returns & Price Chart | Symbol | Recent Dividends |
| Amyris | AMRS | |
| Codexis | CDXS | |
| Gevo | GEVO | |
| ZIOPHARM Oncology | ZIOP | |
| Dividend chart data from Quandl as of today. | ||
To inspect the performance of the Synthetic Biology Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.All 4 stocks are included in the portfolio computations. The current value of the portfolio assumes that $2,500.00 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.
The current value of a $10,000 investment is $10,785. The percent return is 7.85%. The annualized return is 0.95%.
| Return Summary for Synthetic Biology Stocks | |
|---|---|
| Start Date | Feb-29-2012 |
| Start Investment | $10,000.00 |
| End Date | Feb-18-2020 |
| Current Value of Investment | $10,785.42 |
| Total Return | 7.85% |
| Annualized Return | 0.95% |
| Min Date | Apr-30-2013 |
| Min Price | $4,001.45 |
| Max Date | Nov-30-2018 |
| Max Price | $15,767.49 |
| # Monthly Prices | 97 |
| Number Returns | 4,656 |
| Number Profitable Returns | 3,438 |
| Percent Profitable Returns | 73.84% |
| Number Unprofitable Returns | 1,218 |
| Percent Unprofitable Returns | 26.16% |
| Profitable to Unprofitable Returns Ratio | 2.82 |
NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.
Use Stock Symbol and Stock Portfolio Finder to find a stock in a buyupside.com portfolio.
Related Portfolios
Portfolio of Biofuel Stocks
Portfolio of Biotech Stocks
Portfolio of Genomics Stocks